All articles by Emma Davies – Page 7
-
News
Ionic liquids: what the Heck is the promise?
Ionic liquids (ILs) are often hailed as the green saviours of organic chemistry.
-
News
Sanofi-Aventis emerges
Aventis has finally accepted a bid from its French rival Sanofi Synthélabo.
-
News
Raising a toast to cholesterol
Spanish researchers suggest that sherry can help lower cholesterol.
-
News
Chemical concerns for MEPs
Being a member of the European Parliament (MEP) could be a risky occupation.
-
News
Protein target for natural cancer treatment
Enzyme holds key to anti-cancer properties of bacterial product.
-
News
Argenta set to license oncology programme
Argenta's oncology programme is now ready for licensing and the company is 'having serious conversations' over this with several companies.
-
News
Copycat chemistry disarms bugs
Researchers develop protein copies which make bacteria impotent.
-
News
Getting personal with biotechnology
Personalised medicine, which promises to prevent, detect and cure diseases by linking the mechanisms and pathways of illnesses to individuals, will become a reality 'in our lifetime'.
-
News
Double beam dream
Researchers at Rutherford Appleton Laboratory in Oxfordshire, UK, are developing what they claim to be the 'most intense laser in the world'.
-
News
Vernalis buys back migraine drug
Vernalis, the biotech company formed from the merger of British Biotech and the original Vernalis, has bought back the rights to its migraine drug from Irish biotech firm Elan.
-
News
Bernard Henbest (1924-2004)
Bernard Henbest took up the chair of organic chemistry at Queen's University Belfast in 1958 at the age of 33.
-
News
UK government reviews science spending
At a recent breakfast seminar in London, UK chancellor of the exchequer, met with top UK scientists to discuss the future of science.